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Frontotemporal lobar degeneration (FTLD) is a severe neurodegenerative disorder that is
diagnosed with increasing frequency in clinical setting. Currently, no therapy is available
and in addition the molecular basis of the disease are far from being elucidated.
Consequently, it is of pivotal importance to develop reliable and cost-effective in vitro
models for basic research purposes and drug screening. To this respect, recent results
in the field of Alzheimer’s disease have suggested that a tridimensional (3D) environment
is an added value to better model key pathologic features of the disease. Here, we
have tried to add complexity to the 3D cell culturing concept by using a microfluidic
bioreactor, where cells are cultured under a continuous flow of medium, thus mimicking
the interstitial fluid movement that actually perfuses the body tissues, including the
brain. We have implemented this model using a neuronal-like cell line (SH-SY5Y), a
widely exploited cell model for neurodegenerative disorders that shows some basic
features relevant for FTLD modeling, such as the release of the FTLD-related protein
progranulin (PRGN) in specific vesicles (exosomes). We have efficiently seeded the
cells on 3D scaffolds, optimized a disease-relevant oxidative stress experiment (by
targeting mitochondrial function that is one of the possible FTLD-involved pathological
mechanisms) and evaluated cell metabolic activity in dynamic culture in comparison to
static conditions, finding that SH-SY5Y cells cultured in 3D scaffold are susceptible to
the oxidative damage triggered by a mitochondrial-targeting toxin (6-OHDA) and that the
same cells cultured in dynamic conditions kept their basic capacity to secrete PRGN in
exosomes once recovered from the bioreactor and plated in standard 2D conditions.
We think that a further improvement of our microfluidic system may help in providing
a full device where assessing basic FTLD-related features (including PRGN dynamic
secretion) that may be useful for monitoring disease progression over time or evaluating
therapeutic interventions.
Keywords: neurodegeneration, exosomes, progranulin, 3D cell culture, bioreactor, microfluidic, scaffold, cell
modeling
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INTRODUCTION
Neurodegenerative diseases share common pathological
features, such as abnormal protein aggregation, mitochondrial
dysfunction, and disease-specific neuronal degeneration.
Frontotemporal lobar degeneration (FTLD) is a severe
neurodegenerative disorder that is diagnosed with increasing
frequency in clinical setting. It is related to the progressive and
selective degeneration of the frontal lobes, temporal lobes or
both, with relative preservation of the posterior cortical regions.
Its clinical symptoms span from behavioral/dysexecutive
syndrome, language disorders and motor disorders, but the
molecular basis are far from being elucidated and involve several
molecular players including the inflammation-related protein
progranulin (PRGN; Pressman and Miller, 2014; Galimberti
et al., 2015; Irwin et al., 2015).
FTLD therapies aiming at reducing the accumulation of tau
protein and increasing PRGN levels have been explored (Boxer
et al., 2013).
Primary neurons or neuronal-like SH-SY5Y
cells are extensively used as in vitro models for
neurodegenerative disorders. Glass or plastic two-dimensional
(2D) surfaces are important tools to investigate key features
of homogeneous cell populations in an isolated system, but
they show some limitations to assess the relationship between
anatomical and functional connectivity (Bosi et al., 2015).
Conventional 2D culture systems fail to provide topographical
cues, enable cell differentiation into specific phenotypes and fully
reproduce in vivo cell behavior (Lai et al., 2012); furthermore
dissociated neurons cannot be cultured for several weeks.
Organotypic cell cultures allow for a more realistic mimic
of the in vivo situation, since they permit the simultaneous
culturing of cells from functionally related brain regions
while preserving natural cell-to-cell physical contacts (Benam
et al., 2015). The complex physiological three-dimensional
(3D) architecture is partially maintained, but pathways are
largely disconnected because of harvesting injury. Again,
the observation time window may be limited to a few weeks
(Cavaliere et al., 2010; Humpel, 2015; Geuna et al., 2016). To
provide structural and biochemical cues together with a suitable
stiffness and a better control of the cellular context, 3D matrices
such as hydrogels, spheroid-based systems or porous materials
have been exploited as 3D microenvironments (Yamada and
Cukierman, 2007; Zhang et al., 2014). Their main limitation
is related to oxygen and nutrient diffusion. In isolated tissues,
it is limited to 100–200 µm and its availability may influence
cell growth and differentiation (Colom et al., 2014; Liu et al.,
2015). Dynamic culture systems can overcome limited mass
transport, thus contributing to the extension of the culturing
time. In these systems, cells are cultured under a continuous
flow of growing medium, thus mimicking the interstitial fluid
movement that actually perfuses the body tissues, including
the brain. They may also provide fluid mechanical loading
acting as a physiologically relevant stimulus for cell metabolic
activity, if suitable mathematical and computational models
are used to achieve the proper bioreactor design (Sacco et al.,
2011). In addition, dynamic conditions may better reproduce
pathology-relevant features, such as protein seeding and
spreading across cells, that is relevant also for FTLD (Jucker
and Walker, 2011). However, together with the accumulation
of abnormal protein aggregates, other mechanisms such
as oxidative stress are involved in the degenerative process,
as reported in FTLD linked to mutations in tau protein
(Martínez et al., 2008). Martínez et al. (2008) have evidenced
the presence of differences in the extent of oxidative damage
among the types of FTLD; in particular, in FTLD-tau patients
they have observed enhanced lipoxidative damage in the frontal
cortex. Finally, they have suggested that astrocytes are targets
of lipoxidative damage, glial fibrillary acidic protein is modified
by oxidation and astrocytes play a key role in oxidative stress
response.
Microfluidic technology shows several advantages for 3D
cell culture, such as the possibility to model complex dynamic
microenvironments mimicking the in vivo situation in a
controlled and tunable way. In fact, this technique allows to
achieve spatial and temporal control over flows and velocity
gradients in micrometer-sized channels, contributing to extend
the observation time window (Li et al., 2012; van Duinen et al.,
2015). As an example, Moreno et al. (2015) have cultured
human induced pluripotent stem cell-derived neuroepithelial
stem cells differentiated into dopaminergic neurons for 30 days
in arrays of microfluidic bioreactors in a microtiter plate
format.
In this work, we have optimized a miniaturized, microfluidic,
3D scaffold-based perfusion bioreactor as a simple, reproducible
and reliable platform for in vitro modeling of basic research
features of FTLD.
MATERIALS AND METHODS
The Miniaturized, Microfluidic and
Optically Accessible Bioreactor
The miniaturized, microfluidic bioreactor for interstitial
perfusion of 3D cell-seeded scaffolds (Figure 1) was preliminarily
described in a previous study (Laganà and Raimondi, 2012).
Thanks to the optical transparency and low thickness of the
components, it is optically accessible and may be exploited as
a 4D bioreactor for prolonged culture (the 4th dimension is
represented by time). It means that it may be used to assess the
effect of several parameters on engineered tissue growth with
time by viable staining and standard fluorescence microscopy.
This dynamic culture system is composed of three independent
chambers, each hosting one independent scaffold. The chambers
are perfused by three independent microfluidic channels directly
machined in a standard microscope glass slide. Culture medium
is pumped with a flow rate of 5.0 × 10−3 ml/min by a multi-
channel programmable syringe pump (PHDULTRA, Harvard
Apparatus, Holliston, MA, USA) in a gas permeable tubing
system (0.03′′ ID × 0.065′′ OD, Silasticr Tubing, Cole-Parmer,
Vernon Hills, IL, USA) and collected in reservoirs after a single
passage. The scaffolds (of dimensions 6 × 3 × 0.4 mm, 3D
Biotek, Hillsborough, NJ, USA) are made up of polystyrene.
They are obtained by fuse deposition modeling and they
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FIGURE 1 | The miniaturized, microfluidic and optically accessible bioreactor. (A) Sketch of the main components of the 4th dimensional (4D) bioreactor; (B)
The 4D bioreactor is placed on a standard inverted fluorescence microscope and connected to a syringe pump. The arrow indicates a short, gas-permeable tubing
that may be used to connect one chamber to another; (C) Sketch of the culture system hosting the tridimensional (3D) cell-seeded scaffolds; (D) Sketch of the 3D
polystyrene scaffolds; (E) Representation of the culture chambers after the positioning of the 3D cell-seeded scaffolds.
are composed of four layers of fibers (100 µm diameter,
with a pore size of 300 µm) shifted of 150 µm with respect
to the adjacent. After placing the scaffolds, the culture
chambers are sealed by a microscope cover-glass coated with
poly(dimethylsiloxane) (PDMS) and then locked by magnetic
holders.
Cell Culture and Experimental Design
SH-SY5Y human neuroblastoma cells (ATCCr code CRL-
2266TM) are a widely used model for neurodegenerative
disorders. They were cultured at 37◦C and 5% CO2 in high-
glucose Dulbecco’s modified Eagle’s medium supplemented with
10% (v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin and 100 µg/ml streptomycin sulfate (EuroClone, Pero,
Italy) and split twice a week.
To adapt our 4D microfluidic bioreactor for use in
the assessment of potential therapeutic strategies against
neurodegeneration, we have focused on the optimization of the
following experimental protocols (Figure 2A):
1. Cell seeding in 3D scaffolds;
2. Oxidative damage in 3D cell-seeded scaffolds;
3. Evaluation of cell metabolic activity while in dynamic culture.
Finally, we have focused on the demonstration that SH-SY5Y
cells retain their basic capacity to secrete PRGN in exosomes once
recovered from the 4D bioreactor (Figure 2B).
Seeding of Neuronal-like Cells
To increase the seeding efficiency of neuronal-like cells (that
is the number of cells adhering to the 3D scaffolds), the
seeding protocol was optimized starting from a procedure
previously developed for MG-63 osteoblast-like cells (Laganà
and Raimondi, 2012). In sterile conditions, scaffolds were
placed (preferentially in the vertices) in an ultra-low attachment
24-well microplate (Corningr Costarr, Corning, NY, USA) and
incubated overnight with 400 µl culture medium. The following
day, medium was replaced with cell suspension (two seeding
densities were tested: 0.5 and 1·106 SH-SY5Y cells/400 µl). To
achieve full 3D seeding the plate was moved to the incubator and
shaken for 3 h by a 3D multifunction rotator (PS-M3D, Grant
Instruments, VWR, Shepreth, UK) with a protocol alternating
mixing, bending and vibration. To enhance the efficacy of the
dynamic mixing and expose all the samples to the maximum
bending, the microplate was manually rotated clockwise every
15–20 min. The following day the 3D cell-seeded scaffolds were
moved to empty wells and incubated with 400 µl medium.
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FIGURE 2 | Schematic picture of the experimental design. (A) The following experimental procedures were optimized: seeding of SH-SY5Y neuronal-like cells
in 3D scaffolds, oxidative damage in 3D cell-seeded scaffolds by a mitochondrial-targeted toxin (6-OHDA), evaluation of cell metabolic activity while in the 4D
bioreactor; (B) Exosome production and characterization.
To estimate the number of cells seeded in 3D scaffolds,
the samples were incubated with 200 µl sterile distilled water
(EuroClone) and subjected to repeated cycles of freezing at
−80◦C and thawing at 37◦C (30 min each). To improve
cell detachment, during thawing the microplate was placed
on an orbital shaker (Rotamax 120, Heidolph, Schwabach,
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Germany). Two microlitres lysate was pipetted on a NanoQuant
PlateTM and DNA concentration was estimated by measuring
the absorbance (Abs) at 260 nm (Infinite M200 PRO,
Tecan, Männedorf, Switzerland). The blank was automatically
subtracted and a ratio of ∼1.8 was accepted for Abs260/Abs280,
indicating that DNA was of good quality (Zhou et al., 1996).
Since every human diploid cell contains about 6.4 pg DNA













The experiment was run in triplicate and the results were
reported as mean ± standard deviation (SD). As a reference, the
experiment was also performed on 0.5·106 SH-SY5Y cells plated
in a standard 24-well microplate.
Oxidative Damage
SH-SY5Y cells were exposed to 6-OHDA (Sigma-Aldrich,
St. Louis, MO, USA), a toxin applied to produce oxidative
and mitochondrial damage, a feature relevant also for FTLD
models. For example, Bannwarth et al. (2014) identified a FTLD-
amyotrophic lateral sclerosis phenotype in a mitochondrial
disease. To obtain an effective, reproducible and long-lasting
neuronal cell damage, two protocols were compared:
1. One day after seeding (1·106 SH-SY5Y cells), the samples were
incubated overnight with 6-OHDA (250 or 500 µM) in static
conditions;
2. Four days after seeding (0.5·106 SH-SY5Y cells), the samples
were incubated overnight with 6-OHDA (125 or 250 µM)
while shaken on a 3D multifunction rotator with a protocol
alternating mixing and bending.
The 6-OHDA-induced neurotoxicity and its toxic effect over
time were evaluated in terms of reduction of cell metabolic
activity by Alamar Bluer colorimetric assay (resazurin sodium
salt, Sigma-Aldrich). Resazurin is oxidized by mitochondria
and this process results in a color shift from purple/blue
to pink. The amount of color absorption is related to
the amount of metabolically active cells. Culture medium
was replaced with 400 µl working solution (90% (v/v)
culture medium, 10% (v/v) 0.2 mg/ml resazurin sodium salt
in phosphate buffered saline solution, PBS). After 3 h at
37◦C and 5% CO2, 100 µl supernatant was transferred (in
triplicate) in a 96-well microplate (Corningr Costarr). Cell
metabolic activity was estimated by measuring Abs570 (reference
wavelength = 600 nm) or the fluorescence at 590 nm (after
excitation at 560 nm). The experiment was run in triplicate and
the results were reported as mean ± SD after subtracting the
blank.
As an internal control to confirm the toxicity of 6-OHDA,
0.5·106 SH-SY5Y cells were seeded in a 24-well microplate and
incubated with 6-OHDA (250 or 500 µM) in static conditions
the following day.
Metabolic Activity in Dynamic Culture
To exploit the miniaturized bioreactor as a 4D culture
system for quantitative evaluation with time, we identified
the conditions in which comparable results are provided
by Alamar Bluer assay performed in static or dynamic
conditions. 3D scaffolds were seeded with 0.5·106 SH-SY5Y
cells. After verifying that cell metabolic activity was comparable
among the samples (and thus that seeding was a reproducible
process), the cell-seeded scaffolds were cultured in static
conditions in an ultra-low attachment 24-well microplate for
2 days. Then they were divided into two groups: the static
(i.e., kept in the ultra-low attachment microplate) and the
dynamic (i.e., assembled in the 4D bioreactor, where every
culture chamber was connected to a 1 ml syringe and a
reservoir). Cell metabolic activity was evaluated by Alamar
Bluer assay. Static constructs were incubated with 400 µl
working solution, while dynamic constructs were perfused with
working solution at a flow rate of 5.0 × 10−3 ml/min. After
3 h, the fluorescence of supernatants from static (400 µl
each) and dynamic (900 µl each) samples was measured.
Finally, the supernatants from static samples were diluted
with PBS to 900 µl/sample and their fluorescence was
measured again. The experiment was run in triplicate and
the results were reported as mean ± SD after subtracting the
blank.
Cell Recovery From the Bioreactor and
Replating
To demonstrate that SH-SY5Y cells retain their basic capacity
to secrete PRGN in exosomes once recovered from the
4D bioreactor and plated in standard 2D conditions, the
neuronal-like cells were seeded in 3D scaffolds (0.5·106 SH-
SY5Y cells/scaffold). Four days later they were assembled
in the 4D bioreactor, where every culture chamber was
connected to a 20 ml syringe and a reservoir. The constructs
were perfused at a flow rate of 5.0 × 10−3 ml/min for
48 h (dynamic condition), then cells were detached,
counted, plated in a 12-well microplate and expanded in
a T25 cm2 flask and then in T75 cm2 flasks for exosome
isolation.
As a control, SH-SY5Y cells were also seeded in 3D scaffolds
and kept in an ultra-low attachment 24-well microplate (static
condition). The experiment was run in triplicate.
Isolation of Exosomes from Cell Culture
Medium
To test SH-SY5Y cell ability to secrete the frontotemporal
dementia-related protein PRGN, the exosomal fraction was
collected after the cells were kept for 48 h in serum-free
medium. Serum-free media (40 ml/condition, from 6 T75 cm2
flasks/condition) were collected and centrifuged at 300 g for
10 min (4◦C) to eliminate cellular debris. The supernatants were
centrifuged at 2000 g for 10 min (4◦C), at 10,000 g for 30 min
(4◦C) and finally at 100,000 g for 70 min (4◦C). The supernatants
were removed and pellets (exosomes) were suspended in 20 µl
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RIPA lysis buffer (Thermo Fisher Scientific,Waltham,MA,USA)
for further analysis.
Western Blotting
To assess the presence of exosomes, recovered ultracentrifuged
pellets and cell lysates containing 20 µg total proteins (as
assessed by BCA Protein Assay Kit, PierceTM, Thermo Fisher
Scientific) were subjected to 8% SDS-PAGE electrophoresis
and transferred to a nitrocellulose membrane (BioRad
Laboratories, Hercules, CA, USA). The membrane was
incubated with the exosome marker TSG101 monoclonal
primary antibody (1:500, Abcam, Cambridge, UK) for 2 h,
then with a horseradish peroxidase-conjugated secondary
antibody (1:2000, Jackson ImmunoResearch, West Grove,
PA, USA) and finally ECL-detected (Millipore, Billerica,
MA, USA). To semi-quantitatively compare exosome
production from dynamic and static samples, the ratio
between the signal from cell lysate and the corresponding
pellet recovered from ultracentrifugation was quantified
in the resulting impressed film with a free image analyzer
(ImageJ1).
Transmission Electron Microscopy
To characterize the exosomal presence of PRGN, immuno-
electron microscopy was performed on isolated exosomes
from neuronal-like cells recovered from the 4D bioreactor.
A 5 µl drop of purified exosomes in PBS was placed
on a 100 mesh formvar/carbon coated copper grid (EMS,
Hatfield, PA, USA), dried at room temperature for 30
min and fixed with with 4% paraformaldehyde and 0.2%
glutaraldehyde in 0.12 M phosphate buffer (pH 7.4) for
30 min. Exosomes were then incubated overnight at 4◦C
with a rabbit anti-human PRGN antibody (1:100, Invitrogen,
Carlsbad, CA, USA. The specificity of this antibody is detailed
in ‘‘Supplementary Figure 1’’), followed by a donkey anti-
rabbit antibody conjugated to a 12 nm colloidal gold (1:75,
Jackson ImmunoResearch) in block solution for 45 min at
37◦C. After post-fixation with 2% glutaraldehyde, grids were
finally counterstained with uranyl acetate, embedded in LR
White and observed with an Energy Filter Transmission
ElectronMicroscope (EFTEM, ZEISS LIBRAr 120, Oberkochen,
Germany) equipped with YAG scintillator slow scan CCD
camera.
Statistical Analysis
Statistical analysis was performed with GraphPad Prismr
software (GraphPad Software, Inc.). Two-way analysis of
variance (ANOVA) for repeated measurements followed by
Tukey’s multiple comparisons test was used for comparisons
among the groups and time frames, while one-way ANOVA
followed by Tukey’s multiple comparisons test was used for




Seeding of SH-SY5Y Neuronal-Like Cells
on 3D Scaffold
To evaluate the optimal seeding conditions in 3D scaffolds, DNA
content was measured about 24 h after seeding, then the number
of SH-SY5Y cells in 3D scaffolds was estimated as reported in
Methods. As shown in Figure 3, statistical analysis has indicated
that after seeding 0.5·106 SH-SY5Y cells, the number of cells in
3D scaffolds was comparable to the corresponding seeding in
2D condition (ns, p-value > 0.05). As expected, when 1·106 SH-
SY5Y cells were seeded, a greater number of cells was obtained
in 3D scaffolds (∗∗p-value < 0.01) also with respect to the 2D
condition (∗p-value < 0.05), thus confirming that the procedure
did not lead to major cell loss. Morphological analysis has
revealed pore occlusion in the scaffolds seeded with 1·106 cells
because of cell clusters; while the scaffolds seeded with 0.5·106
cells have shown a more homogeneous cell distribution on the
fibers.
Oxidative Damage on 3D Scaffolds
The assessment of 6-OHDA-induced neurotoxicity on SH-SY5Y
cells in 3D scaffolds and its toxicity over time was run with two
procedures differing from incubation mode (static/shaken).The
results (Figure 4) are reported as a function of time post
damage (day 0 is assumed as the day before damage in all
conditions).
At first, scaffolds seeded with 1·106 SH-SY5Y cells were
incubated with 6-OHDA in static conditions 1 day after seeding.
Oxidative damage was induced with 500 µM 6-OHDA, that
reduced cell metabolic activity by 50% with respect to day 0
(∗p-value < 0.05). Cells exposed to the toxic challenge recovered
their metabolic activity on day 2 (ns, p-value > 0.05. Also
on day 5 differences with day 0 were not significant, ns,
p-value > 0.05). We also assessed a different 6-OHDA toxic
concentration (250 µM), but in static conditions this incubation
did not affect cell metabolic activity, that was comparable to
controls at every time point examined.
Then, we performed the oxidative protocol on scaffolds
seeded with 0.5·106 SH-SY5Y cells, that were incubated with
6-OHDA under shaking conditions on a multifunctional rotator
4 days after seeding. The oxidative damage was induced
with 6-OHDA 125 or 250 µM, that reduced cell metabolic
activity by 50% and 80% with respect to day 0, respectively
(∗∗∗∗p-value < 0.0001). Three days later the damage was not
recovered yet (∗∗∗∗p-value< 0.0001).
For scaffolds seeded with 1·106 SH-SY5Y cells and incubated
with 500 µM 6-OHDA in static conditions, morphological
analysis has suggested a reduction in cell density. However,
surviving cells appeared tightly adherent to the scaffold fibers
and cell clusters were still present in the most densely
populated areas. For scaffolds seeded with 0.5·106 SH-SY5Y
cells and incubated with 125 µM 6-OHDA under shaking
conditions, a change in cell morphology was detected. In
fact, most cells assumed a round shape, suggestive of a stress
condition.
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FIGURE 3 | Assessment of cell number and morphology in 3D scaffolds seeded with 0.5·106 or 1·106 SH-SY5Y cells (mean ± SD, n = 3). The seeding of
0.5·106 cells in 2D was considered as a reference. Statistical analysis was performed with one-way ANOVA followed by Tukey’s multiple comparisons test. Ns,
p-value > 0.05; ∗p-value < 0.05; ∗∗p-value < 0.01. Optical micrographs of: (A) 0.5·106 cells/well, 2D; (B) 0.5·106 cells/scaffold; (C) 1·106 cells/scaffold.
Magnification = 4×, scale bar = 100 µm.
The results for 2D controls (0.5·106 SH-SY5Y cells/well,
24-well microplate) have confirmed that the selected 6-OHDA
concentrations (250 or 500 µM) have a strong impact on
SH-SY5Y cell metabolic activity, with a reduction of 88%
and 98% in comparison to untreated controls, respectively
(∗∗∗∗p-value< 0.0001).
Optimization of Dynamic Culture
Conditions of SH-SY5Y Cells
The results depicting cell metabolic activity in 3D scaffolds
seeded with 0.5·106 SH-SY5Y cells and kept in static or
dynamic (i.e., in the 4D bioreactor) conditions are compared in
Figure 5. After 3 h incubation, cell metabolic activity was greater
for SH-SY5Y cells in static conditions (∗∗∗p-value< 0.001).
When the volume of working solution from static samples
was matched to that from perfused samples by adding
PBS, comparable results were obtained (ns, p-value > 0.05).
This has led us to conclude that, as in standard static
conditions, Alamar Bluer assay is a reliable method to
evaluate cell metabolic activity while in dynamic culture. With
respect to the procedure in static conditions, the dynamic
one offers the advantage of a real time monitoring of
cell behavior, without needing to stop the perfusion and
remove the samples from the 4D bioreactor. The initial
results for static samples were greater to those from dynamic
scaffolds because the lower volume of working solution
(400 µl/samples instead of 900 µl) led to a greater resofurin
concentration.
Cell Recovery from the Bioreactor and
Replating
After 48 h culture in the 4D bioreactor, SH-SY5Y cells were
recovered from 3D scaffolds by direct extensive washing
with trypsin solution. After counting, a comparable cell
number was obtained for dynamic (0.46·106 cells, mean
value) and static samples (0.43·106 cells, mean value).
In addition, on day 6 the mean value of specific cell
metabolic activity (that is, the ratio between cell metabolic
activity, assessed by Alamar Bluer assay, and cell number
after detachment) was comparable between the two
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FIGURE 4 | Evaluation of 6-OHDA challenge on SH-SY5Y cells (absorbance values, mean ± SD, n ≥ 3). Metabolic activity as a function of time post
damage for: (A) 1·106 cells/scaffold, incubation with 6-OHDA in static conditions; (B) 0.5·106 cells/scaffold, incubation with 6-OHDA under shaking (“shaken
mode”). Statistical analysis was performed with two-way ANOVA for repeated measurements followed by Tukey’s multiple comparisons test. (C) 0.5·106 cells/well,
incubation with 6-OHDA in static conditions. Their metabolic activity one day after damage was considered as a control. Statistical analysis was performed with
one-way ANOVA followed by Tukey’s multiple comparisons test. Ns, p-value > 0.05; ∗p-value < 0.05; ∗∗∗∗p-value < 0.0001.
conditions (dynamic: 1.13 ± 0.33; static: 0.94 ± 0.19,
mean± SD).
To evaluate their capability to proliferate after dynamic
culture, recovered cells were plated in a 12-well microplate.
Two days later, they were collected, counted (dynamic scaffolds:
1.14·106 cells; static controls: 1.28·106 cells, mean values) and
plated in a T25 cm2 flask. After further 3 days, cells (dynamic:
2.08·106 cells, static controls: 4.5·106 cells; mean values) were
further expanded in T25 cm2 flasks (3 and 4 T25 cm2 flasks,
respectively), while on day 8 after replating they were expanded
in T75 cm2 flasks (7 and 8 T75 cm2 flasks for dynamic and static
cells, respectively).
Overall, a greater than 200-fold increase in cell number
with respect to the day of replating (day 0 is assumed as the
day of replating) was observed for SH-SY5Y cells recovered
from dynamic and static samples. Both cell types did not show
morphological alterations in comparison to standard cultured
cells (Figure 6).
Exosome Preparation from Dynamic
Cultured SH-SY5Y Cells and Assessment
of PRGN Exosomal Content
To test the capability of SH-SY5Y cells to secrete exosomes
after exposure to shear stress due to the perfusion flow of
culture medium under dynamic culture, cells were seeded
in 3D scaffolds, cultured in the bioreactor for 2 days,
then recovered from the scaffolds, plated and expanded as
described. Exosomes were then prepared as described in
‘‘Materials and Methods’’ Section. We were able to efficiently
isolate exosomes from cells cultured in dynamic conditions,
as demonstrated by Western blotting analysis of TSG101
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FIGURE 5 | Cell metabolic activity in 3D scaffolds: static vs. dynamic
(4D bioreactor; fluorescence values, mean ± SD, n = 3). Alamar Bluer
assay was performed on SH-SY5Y cells in 3D scaffolds in static (microplate)
or dynamic (assembled in 4D bioreactor) for 3 h (T incubation). Statistical
analysis was performed with one-way ANOVA followed by Tukey’s multiple
comparisons test. Ns, p-value > 0.05; ∗∗∗p-value < 0.001.
reactivity (Figure 7, top). A comparable ratio between the signal
from cell lysate and the corresponding pellet recovered from
ultracentrifugation was measured for SH-SY5Y cells kept in
dynamic (0.51, mean value) or static condition (0.55, mean
value), suggesting that the tested dynamic culture condition was
not effective in altering exosome production phenotype of SH-
SY5Y cells.
Then, we have further characterized the produced exosomes
for the content of the FTLD-related protein PRGN, that has been
demonstrated to be transported in these vesicles in SH-SY5Y cells
as well as in fibroblasts from patients affected by genetic forms
of FTLD (Benussi et al., 2016). We have performed an electron
microscopy analysis on isolated exosomes to assess whether cells
retain their capability to secrete PRGN in exosomes. As shown
in Figure 7 (bottom), SH-SY5Y cells secrete PRGN in exosomes,
even though PRGN signal was not suggestive of a strong PRGN
content.
DISCUSSION
Microfluidic systems have attracted considerable attention
in basic research as simple, reproducible and cost-efficient
platforms to provide an optimal microenvironment to screen
drug and cell-based therapies (Bhatia and Ingber, 2014). In
FIGURE 6 | Cell recovery from the bioreactor and replating. Top: Brightfield images of cell morphology after replating: static vs. dynamic (48 h in the 4D
bioreactor). SH-SY5Y cells were carefully detached from 3D scaffolds and plated in standard 2D conditions in a 12-well microplate (day 0 was assumed as the day of
replating). On day 2 cells were moved to a T25 cm2 flask, on day 5 they were further expanded in T25 cm2 flasks, while on day 15 their serum-free conditioned
culture medium was collected from T75 cm2 flasks for exosome isolation. Scale bar = 100 µm. Bottom: Fold increase (mean values) in cell number with respect to
the day of replating. Cells were counted after detachment with trypsin.
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FIGURE 7 | Western blot and electron microscopy of exosomes collected from SH-SY5Y cells. Top: Western blotting to detect the presence of the
exosomal marker TSG101, both in the exosome fraction and in the whole cell protein lysate. The comparison to the static condition is also shown. Bottom: The
presence of the FTLD-related protein PRGN was observed in exosomes by electron microscopy. The picture shows the control condition to exclude false positive
signals due to unspecific secondary antibody reactivity (A,B), while the PRGN antibody has highlighted a signal inside exosomes (C,D). The reported bar is the
dimension scale. PRGN: progranulin.
accordance with this need, the miniaturized bioreactor described
in the present work is optically accessible, allowing the direct
and non-destructive observation of cells in 3D polystyrene
scaffolds under a continuous flow of medium. The scaffolds
are obtained by fuse deposition modeling, a rapid prototyping
technique offering the advantage to produce highly defined,
reproducible and fully interconnected architectures. Taken
together, these properties allow to fully control the fluid-
dynamic shear stress acting on the cells adhering to the
3D scaffolds during perfused culture, which does not exceed
a shear level of 12 mPa, as predicted by computational
fluid dynamic simulations (Nava et al., 2013). Thanks to the
controlled perfusion of medium, the 4D bioreactor allows to
maintain a stable oxygen concentration next to the cultured
cells (Raimondi et al., 2015), despite the increase in cell
density occurring within the cell constructs after prolonged
culture.
In this work, we have optimized the 4D microfluidic
bioreactor as an innovative in vitro culture model for the study
of some FTLD-relevant features.
The optimization has begun with the seeding of neuronal-
like SH-SY5Y cells in 3D scaffolds. The starting point was the
procedure described for MG-63 cells (Laganà and Raimondi,
2012). MG-63 human osteoblast-like cells (ATCCr CRL-
1427TM) were seeded at a density of 1·106 cells/scaffold without
scaffold pre-treatment, obtaining an efficiency of 10% (that
is 1·105 cells were recovered 24 h later). The optimized
procedure for SH-SY5Y cells has reported a greater efficiency.
The adhesion of serum peptides and proteins is fundamental
to promote cell adhesion (Tamada and Ikada, 1993), but
polystyrene is a hydrophobic material. To overcome this
limitation, 3D scaffolds were dipped overnight in culture
medium. Fetal bovine serum was also tried, but cells tended
to cluster and fill in the scaffold pores rather than distributing
homogeneously on the fibers (data not shown). To promote cell
penetration in the scaffolds while avoiding their sedimentation
and aggregation, SH-SY5Y cells were seeded with a protocol
alternating mixing, bending and vibration, the same applied for
MG-63 cells. The use of an ultra-low attachment microplate,
the placement of the scaffolds in the vertex wells and the
rotation of the microplate have increased the seeding efficacy,
as suggested by the reduction of the seeding time (about
3 h instead of 5 h). Optical microscopy has shown that cells
are more numerous and uniform when seeded at passages
between 6 and 10 (data not shown). It has also indicated
that seeding 0.5·106 SH-SY5Y cells/scaffold (instead of 1·106)
leads to a more uniform cell distribution, with few scaffold
pores occluded. Overall, we have demonstrated the possibility
of an efficient seeding of neuronal-like cells in the 3D
scaffolds.
Then, we have focused on the development of a toxicity
oxidative damage in 3D conditions also relevant for FTLD. To
this purpose, we have decided to use the toxin 6-OHDA, that
triggers neurotoxicity by forming free radicals and inhibiting
the mitochondrial respiratory chain complexes I and IV (Glinka
et al., 1997). As previously stated, mitochondrial impairment
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is one of the proposed pathogenic pathways involved in
FTLD, and thus its modeling may be of interest. In 2D
experiments, 6-OHDA is typically applied in concentrations
lower than 1 mM (Storch et al., 2000). In this work two
protocols were tested: the first (1·106 cells incubated with
250 or 500 µM 6-OHDA) without shaking and the second
(0.5·106 cells incubated with 125 or 250 µM 6-OHDA) with
the use of a multifunctional shaker. It is likely that the
main difference between the two protocols is due to the
fact that without shaking cell degeneration occurs only in
the outer layers, while the use of a multifunctional rotator
improves the penetration of 6-OHDA by coupling diffusion
and convection. The shaking protocol is similar to that
applied for cell seeding, except for the fact that in this step
vibration was not set to avoid excessive cell stress. With both
protocols we have observed a stable reduction of cell metabolic
activity, but the second one has provided more effective and
reproducible results. However, since a stable damage may be
obtained with a lower toxin concentration, the treatment of
0.5·106 cells with 125 µM 6-OHDA 4 days after seeding
may be a preferable condition. Thus, we have been able
to efficiently damage SH-SY5Y cells seeded in 3D scaffolds
with a mitochondrial-targeted chemical agent. This model
may represent the basis for drug screening or neuroprotective
strategies in a more physiological 3D environment and dynamic
context.
We have also optimized culture conditions in our 4D
bioreactor to measure cell metabolic activity while in culture.
It is worth to note that the assessment of the conditions in
which the results from perfused scaffolds are comparable to
those from similar static samples is an innovative approach. In
fact, in the literature Alamar Bluer or analogous assays are
performed before and after cell culture in a bioreactor, not
during. The main advantages of such assessment are related to
the possibility to perform the assays in dynamic conditions only.
In fact, the same samples can be tested at all the time points
without stopping the perfusion flow of culture medium. This
will allow to save samples and use the same cell culture over
time as internal control, thus improving the reliability of data
analysis.
A few works are available about dynamic culturing of
SH-SY5Y cells. Constantinescu et al. (2007) have successfully
differentiated SH-SY5Y cells to a neuronal-like state in a
perfusion bioreactor. Dynamic culturing of SH-SY5Y cells
has been also tried in rotary bioreactors (Morabito et al.,
2015; Wang and Good, 2001). In this context, Wang and
Good (2001) have observed some differences in cell viability,
neurite extension and nitric oxide production between
dynamic and classical static culture. In this work, we have
provided original data about the effect of shear stress on
SH-SY5Y cell morphology, proliferation and capability to
secrete exosomes, small vesicles that are a current hotspot
in investigations related to neurodegeneration and FTLD.
Our results have indicated that cells retain their spindle-
shaped morphology and capability to proliferate, even
though cells from static scaffolds show a greater proliferation
rate. Cells have also maintained their capability to secrete
exosomes in culture medium and, additionally, we were
able to detect in exosomes the FTLD-related protein PGRN,
confirming the potential relevance of the model for this
kind of dementia. To this respect, as a further refinement
of our in vitro model, we are currently investigating the
presence of PGRN in serum-free culture medium collected
from the bioreactor reservoirs (outlets). As a first attempt,
we have cultured SH-SY5Y cells (1·106 cells/scaffold) for
72 h (48 h with serum-free medium) in the bioreactor. In
these conditions, we were unable to detect the presence of
exosomes in cell-conditioned medium by Western blotting,
likely for an insufficient number of cells, requiring further
scaling-up.
However, the development of reliable and effective in
vitro models of neurodegeneration is strongly limited by
the biological complexity of the brain, the need to produce
neuronal cultures of defined cellular composition, perform
quantitative measurements for validation and provide data
that may be correlated with physiological outputs. Even
though the assessment of functional performances in 3D
systems is much more difficult than in 2D cultures (Benam
et al., 2015), studies in the field of Alzheimer’s disease
have highlighted that a 3D physical microenvironment
and selective chemical signals are key elements to mimic
tissue organization in vivo (Franze et al., 2013). Although
biocompatible, tissue culture-treated polystyrene is stiffer
than extracellular matrix and it fails to reproduce structural,
chemical and physical properties of native brain tissue. To
improve the mimicking of the native tissue, hydrogels
have been extensively exploited (Chen et al., 2010, 2013;
Bersini et al., 2014; Bang et al., 2016). Coating our 3D
polystyrene scaffolds with a suitable hydrogel may improve the
representativeness of our in vitro culture model. In particular,
a collagen/poly(ethylene glycol)-based or a Carbomer/agarose-
based hydrogel (Tunesi et al., 2013, 2015) that we have
previously developed and characterized for central nervous
system applications might be suitable candidates. The first
has shown a better biological performance, but the sol-gel
transition of the second is easier to be tuned in the appropriate
time frame (4–15 min) for loading in the bioreactor culture
chambers.
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